PT  - JOURNAL ARTICLE
AU  - Cunningham, Muriel
ED  - Grossman, Paul Michael
TI  - VLTS-394 Ineffective in the Treatment of Intermittent Claudication
DP  - 2006  01
TA  - MD Conference Express
PG  - 14--14
VI  - 6
IP  - 5
4099  - http://mdc.sagepub.com/content/6/5/14.short
4100  - http://mdc.sagepub.com/content/6/5/14.full
AB  - Patients with peripheral artery disease often experience difficulty walking and painful cramps because of the narrowing of arteries in the legs. This painful condition, known as intermittent claudication (IC), can range in severity from being mildly irritating to extremely debilitating. The efficacy and safety of VLTS-934, a compound believed to increase microvascular blood flow, was evaluated in a Phase 2b randomized, double-blind, placebo-controlled multicenter trial of patients with IC conducted in the United States.